| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.71▲ | 3.71▲ | 3.68▲ | 3.47▲ | 3.44▲ |
| MA10 | 3.71▲ | 3.68▲ | 3.66▲ | 3.36▲ | 3.04▲ |
| MA20 | 3.70▲ | 3.64▲ | 3.53▲ | 3.41▲ | 2.93▲ |
| MA50 | 3.68▲ | 3.45▲ | 3.36▲ | 2.99▲ | 3.68▲ |
| MA100 | 3.65▲ | 3.35▲ | 3.36▲ | 2.92▲ | 3.16▲ |
| MA200 | 3.52▲ | 3.36▲ | 3.20▲ | 3.60▲ | 2.61▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.003▼ | 0.013▲ | 0.012▲ | 0.141▲ |
| RSI | 56.127▲ | 66.829▲ | 79.323▲ | 68.489▲ | 57.792▲ |
| STOCH | 24.537 | 72.391 | 87.321▲ | 60.046 | 75.470 |
| WILL %R | -66.667 | -25.806 | -10.390▲ | -5.826▲ | -5.605▲ |
| CCI | -19.126 | 107.798▲ | 82.900 | 203.592▲ | 124.465▲ |
|
Wednesday, July 02, 2025 07:06 PM
Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the best growth stocks to invest in for the next 5 years. Analysts at H.C. Wainwright have reaffirmed their $10.00 price target on Aquestive ...
|
|
Tuesday, July 01, 2025 05:00 PM
Review the current Aquestive Therapeutics Inc (AQST:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if AQST is the best investment for you.
|
|
Monday, May 26, 2025 04:35 AM
Aquestive Therapeutics, Inc. ( NASDAQ:AQST ) shareholders have seen the share price descend 18% over the month.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/07/25 | 3.69 | 3.7565 | 3.61 | 3.72 | 625,354 |
| 02/07/25 | 3.42 | 3.685 | 3.39 | 3.68 | 1,268,414 |
| 01/07/25 | 3.31 | 3.505 | 3.28 | 3.40 | 1,075,204 |
| 30/06/25 | 3.26 | 3.33 | 3.225 | 3.31 | 1,083,485 |
| 27/06/25 | 3.25 | 3.30 | 3.17 | 3.25 | 2,266,689 |
| 26/06/25 | 3.27 | 3.3262 | 3.14 | 3.25 | 802,827 |
| 25/06/25 | 3.23 | 3.30 | 3.13 | 3.25 | 1,209,872 |
| 24/06/25 | 3.35 | 3.395 | 3.20 | 3.21 | 1,254,801 |
| 23/06/25 | 3.20 | 3.40 | 3.17 | 3.29 | 1,078,768 |
| 20/06/25 | 3.46 | 3.46 | 3.17 | 3.25 | 1,677,475 |
|
|
||||
|
|
||||
|
|